4-PrO-DMT Stats & Data

4‑PrO‑DMT is an O‑propionyl ester that acts mainly as a psilocin prodrug; in vitro/in vivo data with closely related esters and receptor-binding/behavior with 4‑PrO‑DMT support psilocin‑like pharmacology. Expect psilocin‑typical physiological changes and duration, with some users reporting slightly heavier body load and nausea. Psilocin’s human half‑life is around 2–3 h; redosing within the same day stacks unpredictably and is discouraged. Because vendor products vary (freebase vs fumarate; 1:1 vs 2:1 salt), always titrate from a low dose, preferably after an allergy/threshold test session on a different day. For novel/RC tryptamines, prefer oral over vaping: heat can decompose esters to psilocin and organic acids, producing harsh inhalation and inconsistent dosing; several communities report decomposition when smoking/vaping 4‑AcO‑DMT, plausibly similar here. As with other indole tryptamines, an Ehrlich reagent should turn positive (indole), but reagent tests cannot confirm identity or purity; where available, use FT‑IR/GC‑MS drug checking. Beware misrepresentation in unregulated markets; lab testing services note limitations and discourage reliance on vendor‑posted results. Avoid MAOIs and lithium combinations; both have documented severe reactions with serotonergic psychedelics. SSRIs/SNRIs commonly blunt effects—do not compensate by taking more on top. For those on seizure‑threshold–lowering meds (e.g., bupropion, tramadol), avoid or proceed only with medical guidance. Practice standard psychedelic harm‑reduction: do a threshold allergy test first exposure, choose safe set/setting with a sober sitter for higher doses, avoid driving/unsafe environments, and wait at least a week between substantial sessions to minimize tolerance and psychological strain.